358 related articles for article (PubMed ID: 4563804)
21. Delayed cutaneous hypersensitivity reactions to extracts of human tumors.
Herberman RB; Hollinshead AC; Alford TC; McCoy JL; Halterman RH; Leventhal BG
Natl Cancer Inst Monogr; 1973 Jun; 37():189-95. PubMed ID: 4123453
[No Abstract] [Full Text] [Related]
22. Malignancy as a complication of immunosuppressive therapy.
Leibowitz S; Schwartz RS
Adv Intern Med; 1971; 17():95-123. PubMed ID: 4145004
[No Abstract] [Full Text] [Related]
23. A possible role for cross-reacting antigens in conditioning immunological surveillance mechanisms in cancer and transplantation. II. Prospective studies of altered cellular immune reactivity in cancer patients.
Rapaport FT; Lawrence HS
Transplant Proc; 1975 Jun; 7(2):281-5. PubMed ID: 1129846
[No Abstract] [Full Text] [Related]
24. [Clinical aspects of the study of neoplastic antigens].
Lisiewicz J; Moszczyński P
Pol Tyg Lek; 1984 Feb; 39(6):201-4. PubMed ID: 6204325
[No Abstract] [Full Text] [Related]
25. Cancer immunotherapy with surgery.
Orita K; Miwa H; Mannami T; Konaga E; Yumura M
Acta Med Okayama; 1977 Aug; 31(4):217-34. PubMed ID: 145159
[TBL] [Abstract][Full Text] [Related]
26. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
Bloom ET
Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
[No Abstract] [Full Text] [Related]
27. Tumour-associated antigens and tumour-host interactions.
Baldwin RW
Proc R Soc Med; 1971 Oct; 64(10):1039-42. PubMed ID: 4335921
[No Abstract] [Full Text] [Related]
28. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
Takasugi M; Kinoshita K
J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
[No Abstract] [Full Text] [Related]
29. The immunology in cancer.
Bray AE
Surg Gynecol Obstet; 1978 Jul; 147(1):103-8. PubMed ID: 351836
[No Abstract] [Full Text] [Related]
30. Introduction: Immunotherapy of cancer in man, a reality.
Klein E
Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961
[No Abstract] [Full Text] [Related]
31. Immune reactivity to tumor antigens in leukemia and lymphoma.
Leventhal BG; Mirro J; Yarbro GS
Semin Hematol; 1978 Apr; 15(2):157-79. PubMed ID: 148730
[No Abstract] [Full Text] [Related]
32. [Immunology and immunotherapy of lung cancer--experimental and clinical investigations (author's transl)].
Micksche VM
Wien Klin Wochenschr Suppl; 1978; 90():1-28. PubMed ID: 362733
[No Abstract] [Full Text] [Related]
33. Immune surveillance system: its failure and activation.
Shearer WT; Fink MP
Prog Hematol; 1977; 10():247-310. PubMed ID: 337362
[No Abstract] [Full Text] [Related]
34. Cellular immune reactions in human acute leukemia.
Herberman RB
Hamatol Bluttransfus; 1974; 14():107-18. PubMed ID: 4615044
[No Abstract] [Full Text] [Related]
35. [Immunological aspects of melanoma].
Sjögren H
Lakartidningen; 1976 Feb; 73(7):528-30. PubMed ID: 1250045
[No Abstract] [Full Text] [Related]
36. Immunotherapy in patients with melanoma.
Seiger HF; Shingleton WW; Metzgar RS; Buckley CE
Ann Surg; 1973 Sep; 178(3):352-9. PubMed ID: 4269702
[No Abstract] [Full Text] [Related]
37. Lymphocyte stimulation by phytohemagglutinin and tumor cells of malignant effusions.
Robinson E; Sher S; Mekori T
Cancer Res; 1974 Jul; 34(7):1548-51. PubMed ID: 4275697
[No Abstract] [Full Text] [Related]
38. [Stimulation of cellular immunity in patients with malignant tumors].
Govallo VI; Grigor'eva MP; Kosmiadi GA; Vostrikova NA
Vopr Onkol; 1973; 19(12):30-4. PubMed ID: 4544936
[No Abstract] [Full Text] [Related]
39. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM
Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633
[No Abstract] [Full Text] [Related]
40. [Clinical aspects of tumor immunology].
Gorodilova VV
Vopr Onkol; 1973; 19(3):9-17. PubMed ID: 4762704
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
